Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention

European Journal of Anaesthesiology

Volumn 26, Issue 10, 2009, Pages 856-862

  Lazzeri, Chiara ^a   Sori, Andrea ^a   Chiostri, Marco ^a   Gensini, Gian Franco ^a   Valente, Serafina ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Homeostatic model assessment index; Insulin resistance; Nondiabetic; Percutaneous coronary intervention; St elevation myocardial infarction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C PEPTIDE; CREATINE KINASE MB; CREATININE; LACTIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PROGNOSIS; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; FOLLOW-UP STUDIES; HOMEOSTASIS; HOSPITAL MORTALITY; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 74249117519     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832a235c     Document Type: Article

References (36)

1. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329:1988- 1992.
2. Pyörälä M, Miettinen H, Laakso M, Pyö rä lä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year followup results of the Helsinki Policemen Study. Circulation 1998; 98:398- 404. (Pubitemid 28357941)
3. Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334:952-957.
4. Welin L, Eriksson H, Larsson B, et al. Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia 1992; 35:766-770.
5. Ruige JB, Assendelft JJ, Dekker JM, et al. Insulin and risk of cardiovascular disease. A meta-analysis. Circulation 1998; 97:996-1001.
6. Hedblad B, Nilsson P, Engström G, et al. Insulin resistance in nondiabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 2002; 19:470-475.
7. Deedwania P, Kosiborod M, Barrett E, et al., American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117:1610-1619.
8. Webster KA. Stress hyperglycemia and enhanced sensitivity to myocardial infarction. Curr Hypertens Rep 2008; 10:78-84.
9. Ceriello A. Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. Eur Heart J 2005; 26:328-331.
10. Haffner SM, Kennedy E, Gonzalez C, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996; 19:1138-1141.
11. Balkau B, Charles M, for the European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO Consultation. Diabet Med 1999; 16:442-443.
12. Buiatti E, Barchielli A, Marchionni N, et al. Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: results of the acute myocardial infarction Florence registry (AMI-Florence). Eur Heart J 2003; 24:1195-1203.
13. Boden WE, O'Rourke RA, Teo KK, et al., COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356:1503-1516.
14. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined. J Am Coll Cardiol 2000; 36:959-969.
15. Valente S, Lazzeri C, Chiostri M, et al. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 2009; 132:84- 89.
16. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
17. Berglund G, Elmståhl S, Janzon L, Larsson SA. The Malmö Diet, Cancer Study. Design and feasibility. J Intern Med 1993; 233:45-51.
18. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412- 419.
19. Katz A, Nambi S, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402-2410.
20. Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001; 86:5457-5464.
21. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001; 24:1602-1607.
22. Rabasa-Lhoret R, Bastard JP, Jan V, et al. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemia glucose clamp than other fasting-based index of insulin sensitivity in different insulin resistant states. J Clin Endocrinol Metab 2003; 88:4917-4923.
23. Lansang MC, Williams GH, Carroll JS. Correlation between the glucose clamp technique and homeostasis model assessment in hypertension. Am J Hypertens 2001; 14:51-53.
24. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care 1990; 13:631-654.
25. Haffner SM, D'Agostino R, Mykkan̈en L, et al. Proinsulin and insulin concentrations in relation to carotid wall thicknessh. Stroke 1998; 29:1498-1503.
26. Bonora E, Kiechl S, Willeit J, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care 2007; 30:318-324.
27. Tenenbaum A, Adler Y, Boyko V, et al. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease. Am Heart J 2007; 153:559-565.
28. Båvenholm P, Proudler A, Silveira A, et al. Relationship of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease. Thromb Haemost 1995; 73:568-575.
29. Sekiguchi M, Kurabayashi M, Adachi H, et al. Usefulness of insulin resistance measured by homeostasis model assessment in predicting restenosis after coronary stent placement in nondiabetic patients. Am J Cardiol 2004; 93:920-922.
30. Yun KH, Jeong MH, Kim KH, et al. The effect of insulin resistance on prognosis of nondiabetic patients who underwent percutaneous coronary intervention. J Korean Med Sci 2006; 21:212-316.
31. Wallander M, Bartnik M, Efendic S, et al. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia 2005; 48:2229- 2235.
32. Lazzeri C, Tarquini R, Giunta F, Gensini GF. Glucose dysmetabolism and prognosis in critical illness. Intern Emerg Med 2008. [Epub ahead of print]
33. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115:2277-2286.
34. Basi S, Pupim LB, Simmons EM, et al. Insulin resistance in critically ill patients with acute renal failure. Am J Physiol Renal Physiol 2005; 289:F259-F264.
35. Holzinger U, Kitzberger R, Fuhrmann V, et al. Correlation of calculated indices of insulin resistance (QUICKI and HOMA) with the euglycaemic hyperinsulinaemic clamp technique for evaluating insulin resistance in critically ill patients. Eur J Anaesthesiol 2007; 24:966-970.
36. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294:E15-E26.